DekaBank Deutsche Girozentrale’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
WP
PAMS
DekaBank Deutsche Girozentrale's EDIT Position: Q2 2023 in Review
DekaBank Deutsche Girozentrale sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 22,400 shares — an estimated $156K sold.
DekaBank Deutsche Girozentrale first reported a position in EDIT in Q2 2017 and held it in 20 quarters. The position peaked at $1.52M in Q4 2020. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.
- DekaBank Deutsche Girozentrale reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 22,400 Editas Medicine shares in Q2 2023, an estimated $156K.
- DekaBank Deutsche Girozentrale first reported a position in Editas Medicine in Q2 2017 and held it in 20 quarters.
- DekaBank Deutsche Girozentrale's Editas Medicine position peaked at $1.52M in Q4 2020.
- 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.